Navigation Links
Prickly protein
Date:2/6/2014

e deadly than the mutant bacteria, which are unable to form clumps. The experimental model of the disease was a good parallel to the team's test tube experiments.

"The mutant bacteria that don't clump in test tube experiments, don't form vegetations on the heart valves," Horswill explains.

The team then created a version of the mutant bacteria that was also unable to make the giant surface protein. This strain regained the ability of form clumps and also partially regained its ability to cause disease, suggesting that the surface protein is at least partly responsible for both preventing clump formation and for reducing pathogenesis.

"Our study suggests that clumping could be a target for therapy," says Horswill. "If we could find drugs that block clumping, I think they would be potentially really useful for blocking staph infections."

Staph bacteria are the most significant cause of serious infectious disease in the United States, according to the Centers for Disease Control and Prevention (CDC). The bacteria are responsible for life-threatening conditions, including endocarditis, pneumonia, toxic shock, and sepsis. A better understanding of how staph bacteria causes disease may help improve treatment.

The team is now using screening methods to find small molecules that can block clumping. Such molecules will allow the researchers to investigate the clumping mechanism more thoroughly and may also point to therapies that might reduce the illness caused by staph infections.


'/>"/>

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-356-7124
University of Iowa Health Care
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
2. Critical protein discovered for healthy cell growth in mammals
3. Researchers find changes to protein SirT1
4. 2 proteins compete for 1 port on a growth factor; 1 promotes metastasis, the other blocks it
5. NCCS scientists discover gene regulation is dependent on protein ANP32E
6. Better protein capture a boon for drug manufacturers
7. Homemade Protein Bar Recipe Looks to Cut Out Extra Additives from Health Foods, Believes Carol Newman of The BioGirl Health Show
8. New NuGo Stronger: First Non-GMO High Protein Bar with rBGH-Free Whey Protein for Serious Athletes
9. Tricky protein may help HIV vaccine development
10. Research shows molecular, protein targeting therapies may be best treatment for certain lung cancer
11. Rock And Rho: Proteins that help cancer cells groove
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prickly protein
(Date:4/20/2015)... April 20, 2015 Western Connecticut ... DNP, RN, NEA-BC, FAAN who was named The ... and Research in September 2014, is transitioning from ... to lead the development of Western Connecticut Health ... created role, Donahue will be responsible for the ...
(Date:4/20/2015)... NJ (PRWEB) April 20, 2015 The normal ... stroke. There’s nothing more we could do.” Especially if the ... , Today, the response should be much different. So it’s ... question: “What more can be done?” , Not every ... “There is something that can be done.” But, according to ...
(Date:4/20/2015)... 2015 America’s Health Insurance Plans ... insurance industry, is seeking greater regulation of medical ... involving surgical tools called power morcellators ( http://www.morcellatorlawsuit2015.com ... Casey (D-PA) dated April 14th, the group asserted ... to “serious gaps in the current approval and ...
(Date:4/20/2015)... Mesa, CA (PRWEB) April 20, 2015 ... on TROY Secure Print Enterprise (TSPE) software, which provides ... Michigan on Wednesday, May 6 at the Anthem Suite ... Street from 7 to 11 AM. , Beginning at ... breakfast. Starting at 8 AM, TROY Healthcare Solutions will ...
(Date:4/20/2015)... Today the members of the new Stand ... Alliance-National Ovarian Cancer Coalition Translational Research Dream Team ... “DNA Repair Therapies for Ovarian Cancer,” building on ... a common weakness in ovarian cancer. Researchers will ... ovarian cancer by developing a web-based approach to ...
Breaking Medicine News(10 mins):Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4
... March 19 The Pennsylvania,Breast Cancer Coalition (PBCC) will ... at the University of Pennsylvania in the Flyers-76ers,Surgery Theatre ... and Spruce,Streets, to publicize this year,s Income Tax Check-Off ... the eight researchers,who have been selected to receive research ...
... Association Developing New Internet Drug Distributor Identification,Program, ... are now only second to marijuana in the ... street drugs, prescription drugs are,just as dangerous when ... the supervision of a health care practitioner. So ...
... ARLINGTON, Va., March 19 Yesterday,bipartisan groups of ... and,17 U.S. Senators sent letters to the Centers ... the impact of a new Medicare,competitive bidding program ... ask CMS to release data on how the ...
... Chemically altered form of natural compound found in heparin ... health officials say they,ve identified the contaminant found in ... of allergic reactions and possibly 19 deaths in the ... called oversulfated condroitin sulfate, but U.S. Food and Drug ...
... To accommodate rapid growth and,further enhance PRA,s ability to ... office to a larger, more centrally located,facility. By more ... new,location includes more offices and conference and meeting spaces, ... clinical operations,staff while allowing for future expansion of the ...
... (Kingston, ON) Determining how the HIV/AIDS epidemic increases ... be done to reduce the chances of this happening ... , Both Canadian and Southern African expertise ... in policy advocacy around this crucial issue. , Funded ...
Cached Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces Event at the University of Pennsylvania Hospital to Celebrate the 2008 Income Tax Check-Off Campaign 2Health News:NABP Supports White House's Commitment to End Illegal Internet Drug Sales 2Health News:Medicare Bidding Program for Durable Medical Equipment May Harm Small Businesses and Decrease Patient Access to Care, Say 137 Members of Congress 2Health News:Medicare Bidding Program for Durable Medical Equipment May Harm Small Businesses and Decrease Patient Access to Care, Say 137 Members of Congress 3Health News:FDA Identifies Contaminant in Blood-Thinning Drug 2Health News:FDA Identifies Contaminant in Blood-Thinning Drug 3Health News:PRA International Announces New Office Opening in Mumbai 2Health News:Food insecurity linked with HIV/AIDS in Africa 2
(Date:4/20/2015)... Increasing unnecessary regulations on drug plans could inflict higher ... medications through a managed drug plan, according to a ... Analysis Senior Fellow Devon Herrick. "The ... helps makes medications affordable," says Herrick. "Blatant protectionism through ... protections, but more often than not they are designed ...
(Date:4/20/2015)... 20, 2015 Stand Up To Cancer (SU2C) and the ... million Dream Team to attack the number one cancer killer ... of the American Association for Cancer Research (AACR), Scientific Partner ... in the United States will be ... will die from it, making lung cancer the leading cause ...
(Date:4/20/2015)... 2015 Eli Lilly and Company (NYSE: ... was statistically superior to placebo in the treatment of ... the proportion of patients achieving an ACR 20 response. ... 20 percent reduction in disease signs and symptoms as ... During the 24-week, Phase 3 study, titled SPIRIT-P1, patients ...
Breaking Medicine Technology:Restrictive Drug Plan Regulations Will Hurt Patients 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... QUEBEC CITY, Oct. 2 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... patient recruitment for its Phase 2 trial in ... agonist,linked to doxorubicin. The decision to enter the ...
... integrated neurohormonal ... to obesity pharmacotherapy, SAN DIEGO, Oct. 1 Amylin ... for its pipeline obesity,candidates will be presented at the 2008 ... The Obesity Society,s annual,meeting is one of the largest and ...
Cached Medicine Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: